Cargando…
DDRE-03. IDH1-MUTANT GBM CELLS ARE HIGHLY SENSITIVE TO COMBINATION OF KDM6A/B AND HDAC INHIBITORS
Mutations in IDH1 and IDH2 genes are common in low grade gliomas and secondary GBM and are known to cause a distinct epigenetic landscape in these tumors. To interrogate the epigenetic vulnerabilities of IDH-mutant gliomas, we performed a chemical screen with inhibitors of chromatin modifiers and id...
Autores principales: | Kayabölen, Alişan, Sahin, Gizem Nur, Seker, Fidan, Cingöz, Ahmet, Isik, Bekir, Acar, Simge, Wakimoto, Hiroaki, Cahill, Daniel P, Solaroglu, Ihsan, Cribbs, Adam, Oppermann, Udo, Bagci-Onder, Tugba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992211/ http://dx.doi.org/10.1093/noajnl/vdab024.025 |
Ejemplares similares
-
IDH Mutations in Glioma: Double-Edged Sword in Clinical Applications?
por: Kayabolen, Alisan, et al.
Publicado: (2021) -
The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme
por: Kaya-Aksoy, Ezgi, et al.
Publicado: (2019) -
Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma
por: Senbabaoglu, Filiz, et al.
Publicado: (2020) -
The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma
por: Ozyerli-Goknar, Ezgi, et al.
Publicado: (2019) -
Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives
por: Seker-Polat, Fidan, et al.
Publicado: (2022)